SEC Form 4 · accession 0001022079-18-000088
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J. E. Davis
Officer — EVP, General Diagnostics
Period of report
Mar 2, 2018
Accepted (ET)
Mar 6, 2018 · 7:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 2, 2018 | A | 11,886 | $101.00 | A | 48,909 | D | |
| Common StockF2,F3 | Mar 2, 2018 | F | 6,764 | $101.00 | D | 42,189 | D | |
| Common Stock | Mar 5, 2018 | S | 5,122 | $101.00 | D | 37,067 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 23, 2015, approved in accordance with the requirements of Rule 16b-3(d).
- F2Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.
- F3The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
- F4The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 28, 2017.